| Chronic Lymphocytic Leukemia |
1 |
1 |
| Small Lymphocytic Lymphoma |
0 |
0.9 |
| Biologic Therapy |
0 |
0.8 |
| CAR-T |
0 |
0.76 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.41 |
| B-Cell Lymphoma |
0 |
0.31 |
| Lymphoma |
0 |
0.26 |
| Cytokines |
0 |
0.17 |
| Refractory |
0 |
0.17 |
| Antigens |
0 |
0.09 |
| California |
0 |
0.09 |
| Drug Resistance |
0 |
0.09 |
| Food and Drug Administration (FDA) |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Leukemia |
0 |
0.09 |
| Receptors |
0 |
0.09 |
| Remission |
0 |
0.09 |
| Tyrosine Kinase |
0 |
0.09 |